Selank · Mechanism of Action
Mechanism of Action
Quick answer
Published research describes Selank in terms of tuftsin / immunomodulatory pathways and related signaling. This is a generic summary of laboratory findings, not a statement about effects in people.
In published research, Selank (Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro)) is characterized as a research peptide that is studied primarily through its interaction with tuftsin / immunomodulatory pathways. The summary below describes the mechanisms reported in the scientific literature at a molecular level. It is educational reference information about laboratory study models, not a description of effects in humans.
Reported molecular targets
The research literature associates Selank with tuftsin / immunomodulatory pathways, GABAergic and monoaminergic signaling (reported), and BDNF expression (reported). These are the interaction points most frequently referenced when the compound is discussed in mechanistic studies.
As with any research material, the precise pathways reported vary by model system, and findings are drawn from in-vitro and preclinical work rather than human data.
- Primary target
- tuftsin / immunomodulatory pathways
- Also referenced
- GABAergic and monoaminergic signaling (reported)
- Also referenced
- BDNF expression (reported)
Where this mechanism is studied
Mechanistic work involving Selank appears most often in the context of anxiolytic research, nootropic model studies, and immunomodulation research. Investigators use these model systems to characterize the compound's behavior, not to establish any human application.
Selank is profiled here as laboratory reference information; Blueprint Labs stocks related research compounds rather than Selank itself.
Reading this responsibly
Mechanistic descriptions summarize what researchers have reported about molecular interactions. They are not evidence of safety or benefit in any organism, and they are not instructions for use. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Questions, answered
What is the reported mechanism of Selank?
Published research describes Selank in terms of tuftsin / immunomodulatory pathways and related signaling. This is a generic summary of laboratory findings, not a statement about effects in people.
Does this describe what Selank does in humans?
No. Everything here summarizes in-vitro and preclinical research models. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Is Selank a small molecule or a peptide?
Selank is classified as a research peptide (molecular weight 751.90 g/mol).